Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.
It took decades for scientists to come up with treatments that could slow the progression of Alzheimer’s disease. Now patients and physicians face a new challenge: actually getting the medicines to people who might benefit from them. Join us for a conversation with a practicing neurologist, neuroscientist and geriatrician about overcoming current hurdles involved in diagnosing, treating, and monitoring patients in a new era for Alzheimer’s disease.
